Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1726 to 1740 of 7682 results

  1. TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MT512)

      Status ...

    Medical technologies guidance
    Topic selection

  2. Bladder EpiCheck for the detection of bladder cancer recurrence (MT706)

      Status ...

    Diagnostics guidance
    Topic selection

  3. Cenobamate for adjunctive treatment of primary generalised tonic-clonic seizures in epilepsy TS ID 10214

    Awaiting development [GID-TA11069] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  4. Mavorixafor for treating WHIM syndrome ID3946

    Awaiting development [GID-TA10833] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  5. Safe prescribing and withdrawal management of prescribed drugs associated with dependence and withdrawal

    Awaiting development [GID-QS10106] Expected publication date: TBC

    Quality standard
    Awaiting development

  6. Ixazomib citrate for maintenance treatment of untreated multiple myeloma after autologous stem cell transplant [ID1517]

    Awaiting development [GID-TA10843] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  7. Safeguarding adults in care homes

    Awaiting development [GID-QS10147] Expected publication date: TBC

    Quality standard
    Awaiting development

  8. Istradefylline with levodopa for treating motor fluctuations in Parkinson's disease [ID3868]

    Awaiting development [GID-TA10773] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  9. Sparsentan for treating focal segmental glomerulosclerosis in people 8 years and over [ID3955]

    Awaiting development [GID-TA10867] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  10. Baloxavir marboxil for treating influenza in people at high risk of complications [ID3794]

    Awaiting development [GID-TA10683] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  11. Belimumab with rituximab for treating systemic lupus erythematosus [ID3967]

    Awaiting development [GID-TA10869] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  12. Pembrolizumab with neoadjuvant chemotherapy and adjuvant endocrine therapy for treating ER-positive, HER2-negative early breast cancer [ID3993]

    Awaiting development [GID-TA10896] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  13. Liposomal cytarabine–daunorubicin for treating relapsed or refractory acute myeloid leukaemia in people aged 1 to 21 years [ID4017]

    Awaiting development [GID-TA10916] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  14. Bupivacaine–meloxicam for treating postoperative pain [ID2728]

    Awaiting development [GID-TA10716] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. Dasatinib for treating Philadelphia-chromosome-positive acute lymphoblastic leukaemia in children and adults ID1297

    In development [GID-TA10311] Expected publication date: TBC

    Technology appraisal guidance
    In development